Yinghong Zhang, Jichao Zhou, Zhidi Zhang, Chiyu Xu, Haipeng Zhou, Yanrong Ren, Li Zhu, Yi Wang
Department of otorhinolaryngology, Peking University Third Hospital, Beijing 100191, China.
Department of Ophthalmology, Peking University Third Hospital, Beijing 100191, China.
Am J Otolaryngol. 2023 Mar-Apr;44(2):103692. doi: 10.1016/j.amjoto.2022.103692. Epub 2022 Nov 18.
Dysthyroid optic neuropathy (DON) is a serious complication of thyroid-associated ophthalmopathy (TAO) that can cause permanent vision loss from orbital apex syndrome. Urgent management of high-dose corticosteroid pulse therapy is recommended, and salvage orbital apex decompression surgery may require in refractory patients ineffective with corticosteroid pulse therapy.
To evaluate the short-term efficacy and safety of combined endoscopic endonasal and orbital approach decompression in the annulus of the Zinn (AZ) area in refractory dysthyroid optic neuropathy (DON).
In this retrospective study, patients who underwent combined endoscopic endonasal and orbital approach decompression around the AZ area for the treatment of refractory DON from May 2021 to March 2022 were enrolled. A total of 15 orbital apex were decompressed across 9 patients. The demographic, imaging, and surgical data, as well as preoperative and postoperative best corrected visual acuity (BCVA), proptosis degree and Modified-Chinese-TAO-QOL scores, were collected and assessed. The t-test was used to identify differences between preoperative and postoperative parameters: visual acuity, proptosis and QOL scores.
The mean best corrected visual acuity (BCVA) improved from 0.79 ± 0.77 LogMAR preoperatively to 0.21 ± 0.27 LogMAR (P < 0.001) postoperatively. Additionally, proptosis decreased from 22.25 ± 2.01 mm to 18.42 ± 1.85 mm (P < 0.01), with an average decrease of 3.7 mm. The preoperative scores of the visual, psychological, and comprehensive components of QoL were 14.60 ± 9.08, 37.49 ± 6.26 and 26.75 ± 3.70, respectively, which significantly improved postoperatively to 54.18 ± 7.23, 68.78 ± 12.53 and 61.88 ± 9.37, respectively. The postoperative follow-up time ranged from 2 to 11 months, and the median follow-up time was 7 months. There was 1 case of transient postoperative sinusitis and 1 new case of transient diplopia, which was relieved after 3 months.
Combined endoscopic endonasal and orbital approach adequate decompression for AZ area significantly improves visual acuity and QOL in patients with DON.
甲状腺功能异常性视神经病变(DON)是甲状腺相关眼病(TAO)的一种严重并发症,可因眶尖综合征导致永久性视力丧失。建议紧急采用大剂量糖皮质激素冲击疗法进行治疗,对于糖皮质激素冲击疗法无效的难治性患者可能需要进行挽救性眶尖减压手术。
评估经鼻内镜联合眼眶入路对Zinn环(AZ)区域进行减压治疗难治性甲状腺功能异常性视神经病变(DON)的短期疗效和安全性。
在这项回顾性研究中,纳入了2021年5月至2022年3月期间因难治性DON接受经鼻内镜联合眼眶入路在AZ区域周围进行减压治疗的患者。9例患者共15个眶尖接受了减压。收集并评估患者的人口统计学、影像学和手术数据,以及术前和术后的最佳矫正视力(BCVA)、眼球突出度和改良中国TAO-QOL评分。采用t检验确定术前和术后参数(视力、眼球突出度和生活质量评分)之间的差异。
最佳矫正视力(BCVA)平均从术前的0.79±0.77 LogMAR提高到术后的0.21±0.27 LogMAR(P<0.001)。此外,眼球突出度从22.25±2.0 < 原文中此处单位有误,推测应为mm > 1mm降至18.42±1.85mm(P<0.01)(此处原文单位有误,推测应为mm),平均下降3.7mm。术前生活质量的视觉、心理和综合成分评分分别为14.60±9.08、37.49±6.26和26.75±3.70,术后分别显著提高至54.18±7.23、68.78±12.53和61.88±9.37。术后随访时间为2至11个月,中位随访时间为7个月。有1例患者术后出现短暂性鼻窦炎,1例患者出现新的短暂性复视,3个月后缓解。
经鼻内镜联合眼眶入路对AZ区域进行充分减压可显著提高DON患者的视力和生活质量。